C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
11/2004
11/25/2004	WO2004100961A1 Sulfate group transferase inhibitor
11/25/2004	WO2003101405A3 Aminoglycoside antibiotics and methods of using same
11/25/2004	US20040236086 Method of preparing 4-R-substituted 4-demethoxydaunorubicin
11/25/2004	US20040235786 Highly purified antiendotoxin compound
11/25/2004	US20040235762 Host vs. graft disease, leukemia, lymphoma; autoimmune disorders; fungicides; antitumor and antiproliferative agents
11/25/2004	CA2525907A1 Rapamycin carbohydrate derivatives
11/24/2004	EP1479799A1 Fibrous nano self-assemblies
11/24/2004	CN1548446A Isopamicin and its salt and their prepn
11/24/2004	CN1176714C Method and composition for treating prostate cancer
11/23/2004	US6821761 Sphingolipid ceramide N-deacylase, methods for producing sphingolipids and sphingolipid derivatives, and sphingolipid ceramide N-deacylase gene
11/18/2004	WO2004099135A2 Hiv prodrugs cleavable by cd26
11/18/2004	WO2004098644A1 Prodrugs cleavable by cd26
11/18/2004	US20040229884 Sodium channel blockers
11/18/2004	US20040229845 Modified PSMA ligands and uses related thereto
11/18/2004	US20040229265 Amino-modified polysaccharides and methods of generating and using same
11/18/2004	CA2525191A1 Prodrugs cleavable by cd26
11/18/2004	CA2517338A1 Hiv prodrugs cleavable by cd26
11/17/2004	EP1477493A1 Isotope coded affinity tags
11/17/2004	EP1476426A2 Hydroxylated indirubin derivatives
11/17/2004	CN1546504A Rosemary acid anhydride compound ,its preparation method and use for treatment and prevention of AIDS
11/17/2004	CN1546503A Method for preparing polygonin and resveratrol
11/17/2004	CN1546455A Resveratrol oxo acid derivatives, their preparation and pharmaceutical compositions
11/16/2004	US6818657 Bioprecursors of a retinoic derivative and pharmaceutical and/or cosmetic compositions
11/16/2004	CA2265949C Sordarin and derivatives thereof for use as crop antifungal agents
11/11/2004	WO2004096817A1 Solid-phase saccharide sensing compounds
11/11/2004	WO2004072091B1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates
11/11/2004	US20040224904 Carbohydrate scaffold, carrying two side chains, which form a macrocyclic ring that may be unsaturated and contains ether, amide, ester and/or carbamate groups; for therapy of bacterial, fungal, viral or protozoal infections or tumors
11/11/2004	US20040224390 More stable analog of isopropylthiogalactoside for induction of protein expression
11/11/2004	DE19545870B4 Verfahren zur Herstellung der (Meth)acrylsäureester von Kohlehydraten A process for the preparation of the (meth) acrylic acid esters of carbohydrates
11/10/2004	EP1474148A1 Treatment of neuroblastoma
11/10/2004	CN1544447A Ligustrin extracting method
11/09/2004	US6815462 Anticarcinogenic, viricidal, and fungicidal agents; water solubility
11/04/2004	WO2004094646A1 Xyloglucan conjugates useful for modifying cellulosic textiles
11/04/2004	WO2004094445A1 A more stable analog of iso-propylthiogalactoside for induction of protein expression
11/04/2004	WO2004094444A1 6'-amino-6'-deoxygalactosylceramides
11/04/2004	WO2004093821A2 Treatment of anthrax infection using inhibitors of lethal factor protease activity
11/04/2004	US20040220389 Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries
11/04/2004	CA2523263A1 Xyloglucan conjugates useful for modifying cellulosic textiles
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	CN1173987C Enzymatic substrate, synthesis method and uses
11/02/2004	US6812332 Chromogenic substrates of sialidase and methods of making and using the same
11/02/2004	US6812331 Aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments
11/02/2004	US6812037 Antimitotic compounds
10/2004
10/28/2004	WO2004092329A2 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines
10/28/2004	CA2522213A1 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines
10/27/2004	EP1470143A1 Compounds that inhibit factor xa activity
10/27/2004	EP1470104A2 Novel compounds that inhibit factor xa activity
10/27/2004	CN1541096A Compounds which mimic chemical and biological properties of discodermolide
10/27/2004	CN1539844A 2,3,5,4'-tetrahydroxy diphenyl ethylene-2-1-beta-D-glucoside
10/27/2004	CN1172948C New pentasaccharides, their methods of production and pharmaceutical compositions containing same
10/21/2004	US20040210047 such as epoxymethallyl glycerol monomers; for use as epoxies, adhesives, coatings and composites; thermosets
10/21/2004	US20040209841 Association compound of trehalose or maltitol with metal ion compound
10/21/2004	US20040209828 Solvent-free anthracycline derivatives
10/21/2004	US20040208884 Administering construct in conjugated or unconjugated form and in combination with immunogenic carrier to induce antibodies; anticarcinogenic agents
10/21/2004	US20040208875 Method for treating amyloidosis
10/21/2004	US20040208822 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis
10/21/2004	DE19720496B4 Verfahren zur Hydrierung von Zuckern oder Zuckergemischen zu Zuckeralkoholen oder Zuckeralkoholgemischen Process for hydrogenating sugars or sugar mixtures to sugar alcohols or sugar alcohol mixtures
10/19/2004	US6805873 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
10/19/2004	CA2238574C Targeted cytotoxic anthracycline analogs
10/14/2004	WO2004087727A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
10/14/2004	WO2004087726A1 Novel nitrile glycoside useful as a bio-enhancer of drugs and nutrients, process of its isolation from moringa oleifera.
10/14/2004	US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/14/2004	US20040204425 Sodium channel blockers
10/13/2004	EP1466607A1 Compositions for the treatment of primary and metastatic neoplastic diseases using arsenic compounds in combination with all-trans retinoic acid
10/13/2004	EP1465854A2 Chalcone derivatives and their use to treat diseases
10/13/2004	EP1465661A1 Cancer treatment
10/13/2004	EP1465582A1 Alkyl- and/or alkylene oligoglycoside betaine ester quaternaries
10/13/2004	EP1347987B1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/13/2004	EP1250095B1 Versatile hydrophilic dyes
10/13/2004	EP1055682B1 Novel substances kf-1040 and process for producing the same
10/13/2004	CN1535974A Method for producing glucolipid substance using ganglioside as main component
10/12/2004	US6803456 Used in prevention and treatment of atherosclerosis and as a dietary supplement; nutraceuticals
10/07/2004	WO2004085452A1 Compound having affinity with calcified tissue
10/07/2004	WO2004007709A3 Production of polyketides
10/07/2004	US20040198749 Methods of using sodium channel blockers
10/07/2004	US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
10/07/2004	US20040198703 Protecting groups for biological labeling
10/07/2004	US20040198669 Novel nitrile glycoside useful as a bioenhancer of drugs and nutrients, process of its isolation from moringa oleifera
10/07/2004	US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
10/07/2004	US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
10/07/2004	CA2520147A1 Compound having affinity with calcified tissue
10/06/2004	EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004	CN1534040A Preparation method of hongjintian effective component extract
10/06/2004	CN1169820C Puerarin preparing process
10/05/2004	US6800742 Method for producing β-D-ribofuranose derivatives or optical isomers thereof
10/05/2004	US6800741 Alkoxylated surfactants based upon alkyl polyglycoside
10/05/2004	US6800615 Antihelminthic anthraquinones and method of use thereof
10/05/2004	US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
09/2004
09/30/2004	WO2004083228A1 Indolopyrrolocarbazole derivatives and antitumor agents
09/30/2004	WO2004016632A8 Lincomycin derivatives possessing antibacterial activity
09/30/2004	US20040192665 Mesoporphyrin IX covalently linked to doxorubicin; anticarcinogenic, antiproliferative, and antitumor agents; side effect reduction
09/30/2004	US20040192623 Aloe-emodin derivatives and their use in the treatment of neoplasias
09/29/2004	EP1461048A1 Buffalo milk gangliosides
09/29/2004	EP1461014A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
09/29/2004	CN1533442A Cimeric immunomodulatory compounds and methods of using the same
09/29/2004	CN1168763C Process for continuously extracting corn protein, olgiose, saponin and nucleic acid from corn germs
09/29/2004	CN1168733C Novel prodrugs for therapy of tumors and inflammatory disorders
09/29/2004	CN1168732C Lower alkyl alcohol recovery from a stripping mixture
09/28/2004	US6797725 Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
09/28/2004	US6797496 Reacting lactose with alcohol in presence of glucosidase/hydrolase; useful as foods/medicines

1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 180